Cobalt-57 bleomycin for imaging head and neck tumors
- 1 May 1979
- Vol. 43 (5) , 1652-1657
- https://doi.org/10.1002/1097-0142(197905)43:5<1652::aid-cncr2820430514>3.0.co;2-i
Abstract
Cobalt-57 bleomycin imaging was performed in 11 patients with a history of head and neck cancer. Clinical and scan findings concurred on the presence and extent of tumor in 9 patients (82%); tumor was present in 7 and absent in 2 of the 9. In 2 patients (18%) the scan demonstrated tumor in the neck but failed to show metastatic sites. Cobalt-57 bleomycin images were of good technical quality, with remarkably low background activity at 24 hours after administration. Cobalt-57 bleomycin imaging appears to be a promising technique for evaluating patients with head and neck tumors.This publication has 5 references indexed in Scilit:
- The place of 57Co-bleomycin scanning in the evaluation of tumorsAmerican Journal of Roentgenology, 1977
- GA-67 SCANNING IN EVALUATION OF THERAPY OF MALIGNANT-TUMORS OF HEAD AND NECK1977
- Clinical Evaluation of Tumor Scanning with57Co-BleomycinRadiology, 1974
- 67Ga as a Diagnostic Agent for the Detection of Head and Neck Tumors and LymphomaRadiology, 1974
- Tumor Scanning with 57Co-BleomycinRADIOISOTOPES, 1972